| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.26 | 4e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |